Downregulation of Carbonic Anhydrase IX Expression in Mouse Xenograft Nasopharyngeal Carcinoma Model Via Doxorubicin Nanobubble Combined with Ultrasound

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2024 Mar 11

PMID 38463523

Authors

Rong Li

Liugui Lu

Zhaoxi Huang

Yong Gao

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to investigate whether doxorubicin nanobubbles (DOX-NB) combined with diagnostic ultrasound (DUS) irradiation could downregulate the expression of carbonic anhydrase IX (CAIX) in mouse xenograft nasopharyngeal carcinoma (NPC) model. In this study, the prepared DOX-NB was round and well dispersed. The average diameter of DOX-NB was 250.9 ± 50.8 nm, with an average polydispersity of 0.321 ± 0.05. The cumulative release of DOX in the DOX-NB + DUS group was significantly higher compared with that of the DOX-NB group ( < 0.05). DOX-NB combined with DUS irradiation could significantly inhibit cell viability ( < 0.05). The expression of CAIX and microvessel density (MVD) in the xenografted tumors was the lowest in the DOX-NB + DUS group compared with that of other groups ( < 0.05). In conclusion, DOX-NB combined with DUS irradiation could improve DOX-NB drug release and synergistically inhibit NPC cell activity. DOX-NB combined with DUS irradiation can downregulate the expression of CAIX in mouse xenograft NPC model. This may be due to the synergistic effect of DUS combined with DOX-NB in reducing MVD in NPC.

References

Chen Y, Li X, Wu S, Xu G, Zhou Y, Gong L . Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis. Med Oncol. 2014; 31(12):304. PMC: 4223533. DOI: 10.1007/s12032-014-0304-1. View

Wang J, Zhao Z, Shen S, Zhang C, Guo S, Lu Y . Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressure. Int J Cancer. 2015; 137(10):2478-91. PMC: 5033025. DOI: 10.1002/ijc.29597. View

Li J, Shi K, Farhadi Sabet Z, Fu W, Zhou H, Xu S . New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy. Sci Adv. 2019; 5(9):eaax0937. PMC: 6731069. DOI: 10.1126/sciadv.aax0937. View

Feng S, Qiao W, Tang J, Yu Y, Gao S, Liu Z . Chemotherapy Augmentation Using Low-Intensity Ultrasound Combined with Microbubbles with Different Mechanical Indexes in a Pancreatic Cancer Model. Ultrasound Med Biol. 2021; 47(11):3221-3230. DOI: 10.1016/j.ultrasmedbio.2021.07.004. View

Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N . Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer Res. 2004; 24(3a):1759-63. View

Zhang Y, Tang N, Huang L, Qiao W, Zhu Q, Liu Z . Effect of diagnostic ultrasound and microbubble-enhanced chemotherapy on metastasis of rabbit VX2 tumor. Med Phys. 2021; 48(7):3927-3935. DOI: 10.1002/mp.14867. View

Rubio-Briones J, Calatrava A, Fernandez-Serra A, Ramos Ruiz R, Iborra I, Garcia-Casado Z . [Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression]. Actas Urol Esp. 2011; 35(2):80-6. DOI: 10.1016/j.acuro.2010.10.003. View

Chowdhury S, Abou-Elkacem L, Lee T, Dahl J, Lutz A . Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook. J Control Release. 2020; 326:75-90. DOI: 10.1016/j.jconrel.2020.06.008. View

Stepien K, Ostrowski R, Matyja E . Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours. Med Oncol. 2016; 33(9):101. PMC: 4971045. DOI: 10.1007/s12032-016-0814-0. View

10.

Chua M, Wee J, Hui E, Chan A . Nasopharyngeal carcinoma. Lancet. 2015; 387(10022):1012-1024. DOI: 10.1016/S0140-6736(15)00055-0. View

11.

Gao W, Li J, Ho W, Chan J, Wong T . Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiation. Sensors (Basel). 2012; 12(7):8832-46. PMC: 3444078. DOI: 10.3390/s120708832. View

12.

Reijnen C, Van Weelden W, Arts M, Peters J, Rijken P, Van de Vijver K . Poor outcome in hypoxic endometrial carcinoma is related to vascular density. Br J Cancer. 2019; 120(11):1037-1044. PMC: 6738053. DOI: 10.1038/s41416-019-0461-2. View

13.

Graham K, Unger E . Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomedicine. 2018; 13:6049-6058. PMC: 6177375. DOI: 10.2147/IJN.S140462. View

14.

Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

15.

Lee V, Kwong D, Leung T, Lam K, Tong C, Lee A . Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma - How far have we achieved?. Crit Rev Oncol Hematol. 2017; 114:13-23. DOI: 10.1016/j.critrevonc.2017.03.030. View

16.

Geis N, Katus H, Bekeredjian R . Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des. 2012; 18(15):2166-83. DOI: 10.2174/138161212800099946. View

17.

Beasley N, Wykoff C, Watson P, Leek R, Turley H, Gatter K . Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 2001; 61(13):5262-7. View

18.

Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S . Management of recurrent nasopharyngeal carcinoma: current perspectives. Onco Targets Ther. 2019; 12:1583-1591. PMC: 6396653. DOI: 10.2147/OTT.S188148. View

19.

Li H, Zhang Y, Shu H, Lv W, Su C, Nie F . Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies. Int J Pharm. 2021; 613:121412. DOI: 10.1016/j.ijpharm.2021.121412. View

20.

Kong L, Wei Q, Hu X, Chen L, Li J . miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway. Med Sci Monit Basic Res. 2019; 25:53-62. PMC: 6394146. DOI: 10.12659/MSMBR.914572. View